Alpha 2.0
Login Register
» Articles » PMID: 37483881

Termination of Palliative Chemotherapy Near the End of Life: A Retrospective Study of Gastrointestinal Cancer Patients

Overview
Journal Palliat Med Rep
Specialty Critical Care
Date 2023 Jul 24
PMID 37483881
Authors
Yoshifumi Matsumoto
Akito Higuchi
Marika Shiba
Kenta Sasaki
Takuro Saiki
Yujiro Honma
Kazuyoshi Kimura
Qiliang Zhou
Yasuo Saijo
Affiliations
Soon will be listed here.
Abstract

Background: Palliative chemotherapy is commonly used for advanced cancer patients. The timing of chemotherapy termination is crucial for efforts to maintain quality of life.

Patients And Methods: This retrospective study included gastrointestinal cancer patients who were treated with chemotherapy and died between 2013 and 2022 at Niigata University Medical and Dental Hospital. Data were reviewed regarding age, gender, cancer type, reason for chemotherapy termination, cause of death, survival after chemotherapy termination, and place of death.

Results: In total, 388 patients were included; the median survival after chemotherapy was 73 days. Patients aged <67 years had shorter survival durations (59 days), compared with patients aged >67 years (82 days). Ten (2.6%) patients began a new chemotherapy regimen, whereas 17 (4.4%) patients received chemotherapy, within 4 weeks before death. The most common reason for chemotherapy termination was disease progression, and most deaths occurred in hospitals.

Conclusion: The rates of chemotherapy and initiation of new chemotherapeutic regimens near the end of life were lower than previously reported. Most deaths occurred in hospitals, highlighting the need for development of hospices.

References
1.
Palmieri L, Dubreuil O, Bachet J, Trouilloud I, Locher C, Coriat R . Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study. Clin Res Hepatol Gastroenterol. 2020; 45(1):101431. DOI: 10.1016/j.clinre.2020.03.029. View
2.
Earle C, Neville B, Landrum M, Souza J, Weeks J, Block S . Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005; 17(6):505-9. DOI: 10.1093/intqhc/mzi061. View
3.
Matsuyama R, Reddy S, Smith T . Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol. 2006; 24(21):3490-6. DOI: 10.1200/JCO.2005.03.6236. View
4.
Ejiri M, Kurose Y, Kasugai Y, Kondo M, Iwata T, Iwamoto S . [A Study on the Status of End-of-Life Chemotherapy for Solid Cancer after the Introduction of New Anti-Cancer Drugs]. Gan To Kagaku Ryoho. 2021; 47(13):2236-2238. View
5.
Hiratsuka Y, Yamaguchi T, Maeda I, Morita T, Mori M, Yokomichi N . The Functional Palliative Prognostic Index: a scoring system for functional prognostication of patients with advanced cancer. Support Care Cancer. 2020; 28(12):6067-6074. DOI: 10.1007/s00520-020-05408-x. View